Customize
Quick Links
Specialties

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Resources>

PER Pulse™ Recaps highlight key points presented in Advances in™ Precision Medicine: The Evolving Role of Genomics and Proteomics in Cancer Treatment: Current and Emerging Roles for Molecular Testing Technologies: Real-World Application into Practice.


Acknowledgment of Commercial Support

This activity is supported by an educational grant from NantHealth.

Advances in™ Precision Medicine: The Evolving Role of Genomics and Proteomics in Cancer Treatment: Current and Emerging Roles for Molecular Testing Technologies: Real-World Application into Practice



Release Date: August 29, 2016
Expiration Date: August 29, 2017
Media: Internet - based

Activity Overview

This two-part activity will focus on the evolving role of genomics and proteomics in treating patients with cancer. Genomics provides insight into the genetic background of tumor cells but is only part of the story. Proteomics takes this insight a step further to shed light on tumor activity related to proteins. How will this combined approach lead to a truly personalized approach to cancer medicine? This activity will combine insight from faculty with highlights from the medical literature in order to get learners up to date in this rapidly growing and exciting field of cancer treatment. 

CME/CE Activity Table of Contents

  • Next-Generation Sequencing (NGS) and Proteomic Testing: An Introduction and Overview
  • Next-Generation Sequencing (NGS) versus Proteomic Testing of Tumor Samples: A Comparison
  • Next-Generation Sequencing and Proteomics: Where Are We Today?
  • The Present-Day Advantages of Genomic Tumor Data … and Future Advantages of Proteomic Tumor Data
  • Proteomic Platforms: An Overview
  • The National Cancer Moonshot: How Can Tumor Testing Analyses Support This?
  • Molecular Testing: Addressing the Challenges of Treating Patients with Cancer

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

This educational activity is primarily directed toward medical oncologists who treat patients with cancer. It is designed to meet the needs of community oncologists. Additionally, fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals (HCPs) involved in the treatment of cancer may also participate.


Educational Objectives

At the conclusion of this activity, participants should be better prepared to:
  • Assess strategies that combine genomic and quantitative proteomic testing in patients with cancer
  • Detail evidence concerning methods and best practices to interpret tumor testing results and personalize the application of chemotherapeutic, targeted, and immunotherapeutic strategies
  • Explain the role of multidisciplinary teams in facilitation and implementation of novel tumor testing technologies in clinical practice settings
  • Apply combined tumor testing technologies to identify patients for clinical trial participation 


Faculty

William J. Gradishar, MD, FASCO, FACP
Betsy Bramsen Professor of Breast Oncology
Director, Maggie Daley Center for Women's Cancer Care
Robert H. Lurie Comprehensive Cancer Center of Feinberg School of Medicine
Northwestern University
Chicago, IL
Disclosure: No relevant financial relationships with commercial interests.

 

Philip C. Mack, PhD
Associate Adjunct Professor
Director of Molecular Pharmacology
UC Davis Comprehensive Cancer Center
Sacramento, CA
Disclosure: Grant/Research Support: Boehringer Ingelheim and Lilly Oncology; Consultant: MolecularMD and Apton.
 




The following individuals have no relevant financial relationships with commercial interests:

The staff of PER®, LLC.


Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER® to ensure the fair balance, independence, objectivity, and scientific objectivity in all of our CME activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.


Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
 
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.
 

Requirements for Successful Completion

·       Once you begin the activity, please answer the demographic questions. This will allow you to proceed to the activity.
·       This activity contains one or more interactive questions. You may move forward through the activity; however, you may not go back to change answers or review content until you finish the activity.
·       At the end of the activity, an “Educational Content” link will be available for you to download content in PDF format for your reference.
·       If you close the Web browser after you complete the activity, the “Educational Content” link will disappear and you will need to review the activity in its entirety to once again access the “Educational Content” link.
·       In order to receive a CME certificate, participants must complete the activity.
·       Click on the “Request Credits” link at the end of the activity. Take the posttest and pass with a score of 70% or higher, complete the evaluation, and then click on “Request Credits.” Participants may immediately download a CME certificate upon completion of these steps.

 

CME Provider Contact Information

Physicians’ Education Resource, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Toll Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705
info@gotoper.com



Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise






Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By